Richard Nolan Townsend, CEO: Lexeo Therapeutics LXEO Sell · Filed 05/20

Trade details

Type: Insider sale
Amount: $16,910.52
Shares · price: 3,342 sh · $5.06 a share
Held after: 336,764 sh
Stock: Lexeo Therapeutics LXEO
Person: Richard Nolan TownsendCEO
Trade date: 26/05/18
Filed: 26/05/20
Days to filing: 2 days

Sold 1.0% of holdings

Share of holding sold: 1.0%

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 04/18~06/17

Richard Nolan Townsend's recent trades

Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.6K
3,345 sh
$16.6K
Filed 08/18
Traded 08/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$116.2K
25,947 sh
$116.2K
Filed 07/01
Traded 07/01
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/18
Traded 05/18
Richard Nolan TownsendCEO
Sell10b5-1 planLexeo Therapeutics
Sell10b5-1 plan
Lexeo Therapeutics
LXEO
$313K
55,000 sh
$313K
Filed 04/07
Traded 04/06
Richard Nolan TownsendCEO
Planned sale10b5-1 planLexeo Therapeutics
Planned sale10b5-1 plan
Lexeo Therapeutics
LXEO
$314.6K
55,000 sh
$314.6K
Filed 04/06
Traded 04/06